By demonstrating the ability of pioglitazone to improve depression-like behaviors through the promotion of a neuroprotective microglial phenotype, we have provided direct evidence supporting the anti-inflammatory function of PPARγ in enhancing mRNA transcription via binding to the IL-10 gene promoter. This evidence concerns the gene PPARG and major depressive disorder.